Obiettivo
The present standard commercially available systems will not allow to meet the time and price goals of large Genome projects. In this proposed project will be demonstrated the performance of a novel device design achieving high accuracy, improving throughput by a factor of 5 to 10, and lowering the cost by the same factor, as compared to the standard systems. The modular design will in the future allow further increase in the throughput to 1 megabase per device per day, since it is today feasible to increase the density of the array detector modules by a factor of 2 to 4. To meet the demands of the Genome projects, highly accurate long reads allowing low redundancy, high throughput DNA sequencing systems together with optimised biochemistry, resulting in much lower sequencing cost, are required. The realisation of an ARAKIS production sequencer for up to 200 samples per run and demonstration of its unmatched performance in large scale routine applications, are the main objectives of the proposed project. This demonstration project is transversal to all biotechnology areas (in particular to new methods for Genome analysis, 2.1 Sequencing and 2.2. Function search) requiring the use of genetic information.
The Arakis is based on the concept of the routinely working novel EMBL Doublex Automated DNA sequencing prototype (design principle and DNA sequencing biochemistry covered worldwide by several patent applications). The system was developed recently at EMBL with funding from the EU Biomed Programme. It gives at present the longest reported readouts (up to 1400 bases per sample), the highest throughput (up to 500 kilobases per device per day) and the highest accuracy resulting in low redundancy (around 2). The multiplex system allows the simultaneous on-line sequencing of two to five DNA templates in one single sequencing reaction. Per sequence reaction up to 7000 bases are thus obtained, 5 to 10 times more than the commercially available systems. The large bottleneck of the automated DNA sequencing, namely the sample loading, has been solved by the porous combs technique developed recently at EMBL, enabling simultaneous loading of 200 samples. The technology, demonstrated in the course of this project, will reduce DNA sequencing costs by a factor of 5 to 10, increase the throughput by the same factor with significantly higher sequencing accuracy (99,8% up to base 500 and 99% accuracy up to base 1000 for double stranded templates per single read), compared to standard commercial devices. Other systems with such performance have not been reported and are not commercially available.
To demonstrate the power and advantages of the new sequencing system in biotechnology, it will be applied to several projects in large scale sequencing, e.g. partial sequencing of microbiological genomes, full length sequencing of cDNAs, genome mapping by end-sequencing of large vectors (BACs, PACs) and gene expression analysis (expression profiling by Serial Analysis of Gene Expression, SAGE) in which 5 to 10 times more information per gel is obtained, shortening correspondingly the projects. From the four multidisciplinary combined partners, one is the technology producer (EMBL, W.Ansorge). The system will be applied to routine projects at the sequencing facility Genoscope (J.Weissenbach) Paris, which is well established in biotechnology and genome analysis, and at University of Amsterdam, (H.F. Tabak), which is experienced in gene expression analysis in yeast and human with the SAGE technique. The start-up company LION will use the system for large scale sequencing in an industrial environment.
The system demonstrated in this project will enhance the attractiveness of this novel technology approach to industrial commercialisation and in service companies, and would give European industry competitive advantage over US and Japanese companies. The partners in this project form the only European collaboration competing at present successfully with the US and Japanese industry in the development of automated DNA sequencing technology.
Keywords : Automated Doublex DNA Sequencing, high throughput sequencing, SAGE
Campo scientifico (EuroSciVoc)
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.
- scienze naturali scienze biologiche biochimica
- scienze naturali scienze biologiche genetica DNA
- scienze naturali scienze biologiche genetica RNA trascrittomi
- scienze naturali scienze biologiche genetica genomi
È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione
Programma(i)
Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.
Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.
Argomento(i)
Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.
Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.
Invito a presentare proposte
Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.
Dati non disponibili
Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.
Meccanismo di finanziamento
Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.
Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.
Coordinatore
69117 HEIDELBERG
Germania
I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.